- Filed
- Nov 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 7, 2024 | 10.84M sh |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $184.53M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $136.22M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $25.23M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $24.57M |
| Cash And Equivalents restated | Q3 2024 · Sep 30, 2023 | $14.09M |
| Cash And Equivalents restated | Q3 2024 · Dec 31, 2022 | $18.31M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $41.55M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $47.7M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $251.9M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $212.4M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $77.94M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $82M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $299.7M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $310.34M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 9.81M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 9.72M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $1.23M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | $19.24M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $39.16M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $51.15M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $68.1M |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$0.53 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$3.04 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$0.53 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$3.04 |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $20.29M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $53.51M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $9.3M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $35.32M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$3.79M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$10.83M |
| Cost Of Revenue restated | Q3 2024 · Sep 30, 2023 | $9.48M |
| Cost Of Revenue restated | Q3 2024 · Sep 30, 2023 | $31.93M |
| Revenue restated | Q3 2024 · Sep 30, 2023 | $39.79M |
| Revenue restated | Q3 2024 · Sep 30, 2023 | $122.79M |